Sexual Function and Quality of Sexual Life in Women With Physical Disabilities

June 27, 2025 updated by: Gozde Yıldız Daş Geçim, Amasya University

The Effect of Sexual and Reproductive Health Training on Sexual Function and Quality of Sexual Life in Women With Physical Disabilities: A Pilot RCT Study From a Turkiye Perspective

This pilot randomized controlled trial will be carried out with women with physical disabilities registered at a disability center. A total of 49 participants will be randomly assigned to either the intervention group or the control group. Following a three-week follow-up period, the study will be completed, with a total of 26 participants: 16 in the intervention group and 10 in the control group . SRH training will be provided to the intervention group once a week, for a total of three sessions. At the beginning and end of the study, both groups will be administered a survey including demographic information, the Sexual Quality of Life Questionnaire-Female (SQLQ-F), and the Female Sexual Function Index (FSFI).

Study Overview

Status

Completed

Conditions

Detailed Description

Background: Ensuring that women with disabilities, who are among disadvantaged groups, maintain and improve their sexual and reproductive health (SRH) on equal terms with other women is of great importance. The purpose of this study is to examine the impact of SRH training provided to women with physical disabilities on their sexual function and quality of sexual life, as well as to assess the feasibility and acceptability of the educational intervention.

Method: This pilot randomized controlled trial will be carried out with women with physical disabilities registered at a disability center. A total of 49 participants will be randomly assigned to either the intervention group or the control group. Following a three-week follow-up period, the study will be completed, with a total of 26 participants: 16 in the intervention group and 10 in the control group . SRH training will be provided to the intervention group once a week, for a total of three sessions. At the beginning and end of the study, both groups will be administered a survey including demographic information, the Sexual Quality of Life Questionnaire-Female (SQLQ-F), and the Female Sexual Function Index (FSFI).

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amasya, Turkey
        • Amasya University Faculty of Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Those who were female between the ages of 18-65, physically disabled, married, did not have a mental health problem, did not have a communication barrier, and volunteered were included in this study.

Exclusion Criteria:

  • being a man
  • having a disability other than physical disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Sexual and Reproductive Health Training program received the intervention group.
'The Sexual and Reproductive Health education program was prepared by researchers who are experts in the field of public health and public health nursing. The program was implemented once a week for 3 weeks (why 3 weeks) in 50-60 minute sessions (Table 1). The content and duration of the application were prepared in accordance with the Ministry of Health Sexual and Reproductive Health: National Strategic Action Plan for the Health Sector (2005-2015) and the Turkey Reproductive Health Program Sexual and Reproductive Health Service Standards (2007). Each program session was two education sessions, and all the questions of the disabled woman were answered .
No Intervention: Control group
no intervention was the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Sexual Life
Time Frame: 1 months
The scale has 6 sub-dimensions: desire, arousal, lubrication, orgasm, satisfaction, and pain (Rosen et al., 2000). Each item is scored from 0 to 5. The highest score that can be obtained from the scale is 95.0, and the lowest score is 4.0.
1 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexual Function
Time Frame: 1 months
The scale is suitable for women aged 18 and over, is a six-point Likert type, and consists of 18 items. Each item is answered by considering the sexual life in the last four weeks. The original version of the scale states that each item can be scored between 1-6 or 0-5. In this study, a 1-6 point system was used (1=I completely agree, 2=I largely agree, 3=I partially agree, 4=I partially disagree, 5=I largely disagree, 6=I completely disagree). The highest score that can be obtained from the scale in the 1-6 point system is 108, and the lowest score is 18.
1 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: zehra incedal sonkaya, PhD, Amasya University
  • Study Chair: murat yücel, PhD, Amasya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 14, 2024

Primary Completion (Actual)

October 14, 2024

Study Completion (Actual)

March 20, 2025

Study Registration Dates

First Submitted

June 18, 2025

First Submitted That Met QC Criteria

June 27, 2025

First Posted (Actual)

June 29, 2025

Study Record Updates

Last Update Posted (Actual)

June 29, 2025

Last Update Submitted That Met QC Criteria

June 27, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disability Physical

Clinical Trials on Sexual and Reproductive Health Training program

Subscribe